A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells

J Biol Chem. 1995 Jan 27;270(4):1670-4. doi: 10.1074/jbc.270.4.1670.

Abstract

In non-differentiated NG108-15 cells, both angiotensin II (Ang II) (100 nM) and CGP 42112 (100 nM) decreased the T-type calcium current amplitude by 24 +/- 2% and 21 +/- 3%, respectively. cGMP is not a mediator of the Ang II effect, since loading of cells with 50 microM cGMP did not prevent the inhibitory effects of Ang II. The effects of Ang II involves a non-identified GTPase activity since incubation with GDP beta S (3 mM) completely reversed the inhibitory effect of Ang II while GTP gamma S mimicked its effect. However, Ang II binding was not affected by GTP gamma S, and the effect of Ang II was not modified in pertussis toxin-treated cells. The inhibitory effect of Ang II on the T-type Ca2+ current involves a phosphotyrosine phosphatase activity since sodium orthovanadate prevented the effects of Ang II, although microcystin-LR, a selective Ser/Thr phosphatase 1 and 2A inhibitor, did not modify the effect of Ang II. These results provide the first evidence of a modulation of membrane conductance by Ang II through the AT2 receptor and demonstrate the involvement of a phosphotyrosine phosphatase and a G protein in the AT2 transduction mechanism in NG108-15 cells. Moreover, our data suggest that phosphotyrosine phosphatase activation is proximal to receptor occupation, since sodium orthovanadate inhibits both GTPase activity and T-type current blockage induced by Ang II or CGP 42112, while GTP gamma S inhibition of the T-type calcium current is not impaired.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / antagonists & inhibitors
  • Angiotensin II / pharmacology*
  • Angiotensin Receptor Antagonists
  • Animals
  • Calcium Channels / physiology*
  • Cyclic GMP / pharmacology
  • GTP-Binding Proteins / metabolism*
  • Glioma
  • Hybrid Cells
  • Kinetics
  • Membrane Potentials / drug effects
  • Neuroblastoma
  • Oligopeptides / pharmacology*
  • Patch-Clamp Techniques
  • Receptors, Angiotensin / physiology*
  • Time Factors

Substances

  • Angiotensin Receptor Antagonists
  • Calcium Channels
  • Oligopeptides
  • Receptors, Angiotensin
  • Angiotensin II
  • CGP 42112A
  • GTP-Binding Proteins
  • Cyclic GMP